475 related articles for article (PubMed ID: 33341150)
1. Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study.
Jabbari E; Koga S; Valentino RR; Reynolds RH; Ferrari R; Tan MMX; Rowe JB; Dalgard CL; Scholz SW; Dickson DW; Warner TT; Revesz T; Höglinger GU; Ross OA; Ryten M; Hardy J; Shoai M; Morris HR;
Lancet Neurol; 2021 Feb; 20(2):107-116. PubMed ID: 33341150
[TBL] [Abstract][Full Text] [Related]
2. DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study.
Trinh J; Gustavsson EK; Vilariño-Güell C; Bortnick S; Latourelle J; McKenzie MB; Tu CS; Nosova E; Khinda J; Milnerwood A; Lesage S; Brice A; Tazir M; Aasly JO; Parkkinen L; Haytural H; Foroud T; Myers RH; Sassi SB; Hentati E; Nabli F; Farhat E; Amouri R; Hentati F; Farrer MJ
Lancet Neurol; 2016 Nov; 15(12):1248-1256. PubMed ID: 27692902
[TBL] [Abstract][Full Text] [Related]
3. Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration.
Sanchez-Contreras M; Heckman MG; Tacik P; Diehl N; Brown PH; Soto-Ortolaza AI; Christopher EA; Walton RL; Ross OA; Golbe LI; Graff-Radford N; Wszolek ZK; Dickson DW; Rademakers R
Mov Disord; 2017 Jan; 32(1):115-123. PubMed ID: 27709685
[TBL] [Abstract][Full Text] [Related]
4. Genetics of Progressive Supranuclear Palsy: A Review.
Wen Y; Zhou Y; Jiao B; Shen L
J Parkinsons Dis; 2021; 11(1):93-105. PubMed ID: 33104043
[TBL] [Abstract][Full Text] [Related]
5. Fine-mapping of the non-coding variation driving the Caucasian LRRK2 GWAS signal in Parkinson's disease.
Heckman MG; Labbé C; Kolicheski AL; Soto-Beasley AI; Walton RL; Valentino RR; Brennan ER; Johnson PW; Baheti S; Sarangi V; Ren Y; Uitti RJ; Wszolek ZK; Ross OA
Parkinsonism Relat Disord; 2021 Feb; 83():22-30. PubMed ID: 33454605
[TBL] [Abstract][Full Text] [Related]
6. Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy.
Ferrari R; Ryten M; Simone R; Trabzuni D; Nicolaou N; Hondhamuni G; Ramasamy A; Vandrovcova J; ; Weale ME; Lees AJ; Momeni P; Hardy J; de Silva R
Neurobiol Aging; 2014 Jun; 35(6):1514.e1-12. PubMed ID: 24503276
[TBL] [Abstract][Full Text] [Related]
7. Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype.
Jabbari E; Woodside J; Tan MMX; Shoai M; Pittman A; Ferrari R; Mok KY; Zhang D; Reynolds RH; de Silva R; Grimm MJ; Respondek G; Müller U; Al-Sarraj S; Gentleman SM; Lees AJ; Warner TT; Hardy J; Revesz T; Höglinger GU; Holton JL; Ryten M; Morris HR
Ann Neurol; 2018 Oct; 84(4):485-496. PubMed ID: 30066433
[TBL] [Abstract][Full Text] [Related]
8. Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases.
Chen JA; Chen Z; Won H; Huang AY; Lowe JK; Wojta K; Yokoyama JS; Bensimon G; Leigh PN; Payan C; Shatunov A; Jones AR; Lewis CM; Deloukas P; Amouyel P; Tzourio C; Dartigues JF; Ludolph A; Boxer AL; Bronstein JM; Al-Chalabi A; Geschwind DH; Coppola G
Mol Neurodegener; 2018 Aug; 13(1):41. PubMed ID: 30089514
[TBL] [Abstract][Full Text] [Related]
9. Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci.
Sanchez-Contreras MY; Kouri N; Cook CN; Serie DJ; Heckman MG; Finch NA; Caselli RJ; Uitti RJ; Wszolek ZK; Graff-Radford N; Petrucelli L; Wang LS; Schellenberg GD; Dickson DW; Rademakers R; Ross OA
Mol Neurodegener; 2018 Jul; 13(1):37. PubMed ID: 29986742
[TBL] [Abstract][Full Text] [Related]
10. Screening for LRRK2 R1441 mutations in a cohort of PSP patients from Germany.
Madzar D; Schulte C; Gasser T
Eur J Neurol; 2009 Nov; 16(11):1230-2. PubMed ID: 19538213
[TBL] [Abstract][Full Text] [Related]
11. RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses.
Gustavsson EK; Follett J; Trinh J; Barodia SK; Real R; Liu Z; Grant-Peters M; Fox JD; Appel-Cresswell S; Stoessl AJ; Rajput A; Rajput AH; Auer R; Tilney R; Sturm M; Haack TB; Lesage S; Tesson C; Brice A; Vilariño-Güell C; Ryten M; Goldberg MS; West AB; Hu MT; Morris HR; Sharma M; Gan-Or Z; Samanci B; Lis P; Periñan MT; Amouri R; Ben Sassi S; Hentati F; ; Tonelli F; Alessi DR; Farrer MJ
Lancet Neurol; 2024 Jun; 23(6):603-614. PubMed ID: 38614108
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsy.
Chen Z; Chen JA; Shatunov A; Jones AR; Kravitz SN; Huang AY; Lawrence L; Lowe JK; Lewis CM; Payan CAM; Lieb W; Franke A; Deloukas P; Amouyel P; Tzourio C; Dartigues JF; ; Ludolph A; Bensimon G; Leigh PN; Bronstein JM; Coppola G; Geschwind DH; Al-Chalabi A
Mov Disord; 2019 Jul; 34(7):1049-1059. PubMed ID: 31059154
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
Noth I; Zhang Y; Ma SF; Flores C; Barber M; Huang Y; Broderick SM; Wade MS; Hysi P; Scuirba J; Richards TJ; Juan-Guardela BM; Vij R; Han MK; Martinez FJ; Kossen K; Seiwert SD; Christie JD; Nicolae D; Kaminski N; Garcia JGN
Lancet Respir Med; 2013 Jun; 1(4):309-317. PubMed ID: 24429156
[TBL] [Abstract][Full Text] [Related]
14. Latent trait modeling of tau neuropathology in progressive supranuclear palsy.
Kouri N; Murray ME; Reddy JS; Serie DJ; Soto-Beasley A; Allen M; Carrasquillo MM; Wang X; Castanedes MC; Baker MC; Rademakers R; Uitti RJ; Graff-Radford NR; Wszolek ZK; Schellenberg GD; Crook JE; Ertekin-Taner N; Ross OA; Dickson DW
Acta Neuropathol; 2021 May; 141(5):667-680. PubMed ID: 33635380
[TBL] [Abstract][Full Text] [Related]
15. Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late-onset Parkinson's disease.
Tan EK; Skipper L; Chua E; Wong MC; Pavanni R; Bonnard C; Kolatkar P; Liu JJ
Mov Disord; 2006 Jul; 21(7):997-1001. PubMed ID: 16602113
[TBL] [Abstract][Full Text] [Related]
16. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.
Höglinger GU; Melhem NM; Dickson DW; Sleiman PM; Wang LS; Klei L; Rademakers R; de Silva R; Litvan I; Riley DE; van Swieten JC; Heutink P; Wszolek ZK; Uitti RJ; Vandrovcova J; Hurtig HI; Gross RG; Maetzler W; Goldwurm S; Tolosa E; Borroni B; Pastor P; ; Cantwell LB; Han MR; Dillman A; van der Brug MP; Gibbs JR; Cookson MR; Hernandez DG; Singleton AB; Farrer MJ; Yu CE; Golbe LI; Revesz T; Hardy J; Lees AJ; Devlin B; Hakonarson H; Müller U; Schellenberg GD
Nat Genet; 2011 Jun; 43(7):699-705. PubMed ID: 21685912
[TBL] [Abstract][Full Text] [Related]
17. Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study.
Rizig M; Bandres-Ciga S; Makarious MB; Ojo OO; Crea PW; Abiodun OV; Levine KS; Abubakar SA; Achoru CO; Vitale D; Adeniji OA; Agabi OP; Koretsky MJ; Agulanna U; Hall DA; Akinyemi RO; Xie T; Ali MW; Shamim EA; Ani-Osheku I; Padmanaban M; Arigbodi OM; Standaert DG; Bello AH; Dean MN; Erameh CO; Elsayed I; Farombi TH; Okunoye O; Fawale MB; Billingsley KJ; Imarhiagbe FA; Jerez PA; Iwuozo EU; Baker B; Komolafe MA; Malik L; Nwani PO; Daida K; Nwazor EO; Miano-Burkhardt A; Nyandaiti YW; Fang ZH; Obiabo YO; Kluss JH; Odeniyi OA; Hernandez DG; Odiase FE; Tayebi N; Ojini FI; Sidranksy E; Onwuegbuzie GA; D'Souza AM; Osaigbovo GO; Berhe B; Osemwegie N; Reed X; Oshinaike OO; Leonard HL; Otubogun FM; Alvarado CX; Oyakhire SI; Ozomma SI; Samuel SC; Taiwo FT; Wahab KW; Zubair YA; Iwaki H; Kim JJ; Morris HR; Hardy J; Nalls MA; Heilbron K; Norcliffe-Kaufmann L; ; ; ; ; Blauwendraat C; Houlden H; Singleton A; Okubadejo NU;
Lancet Neurol; 2023 Nov; 22(11):1015-1025. PubMed ID: 37633302
[TBL] [Abstract][Full Text] [Related]
18. Familial aggregation of parkinsonism in progressive supranuclear palsy.
Donker Kaat L; Boon AJ; Azmani A; Kamphorst W; Breteler MM; Anar B; Heutink P; van Swieten JC
Neurology; 2009 Jul; 73(2):98-105. PubMed ID: 19458322
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy.
Kouri N; Ross OA; Dombroski B; Younkin CS; Serie DJ; Soto-Ortolaza A; Baker M; Finch NCA; Yoon H; Kim J; Fujioka S; McLean CA; Ghetti B; Spina S; Cantwell LB; Farlow MR; Grafman J; Huey ED; Ryung Han M; Beecher S; Geller ET; Kretzschmar HA; Roeber S; Gearing M; Juncos JL; Vonsattel JPG; Van Deerlin VM; Grossman M; Hurtig HI; Gross RG; Arnold SE; Trojanowski JQ; Lee VM; Wenning GK; White CL; Höglinger GU; Müller U; Devlin B; Golbe LI; Crook J; Parisi JE; Boeve BF; Josephs KA; Wszolek ZK; Uitti RJ; Graff-Radford NR; Litvan I; Younkin SG; Wang LS; Ertekin-Taner N; Rademakers R; Hakonarsen H; Schellenberg GD; Dickson DW
Nat Commun; 2015 Jun; 6():7247. PubMed ID: 26077951
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women.
Verdiesen RMG; van der Schouw YT; van Gils CH; Verschuren WMM; Broekmans FJM; Borges MC; Gonçalves Soares AL; Lawlor DA; Eliassen AH; Kraft P; Sandler DP; Harlow SD; Smith JA; Santoro N; Schoemaker MJ; Swerdlow AJ; Murray A; Ruth KS; Onland-Moret NC
Hum Reprod; 2022 May; 37(5):1069-1082. PubMed ID: 35274129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
